ATYR PHARMA INC (ATYR) Stock Analyst Ratings
NASDAQ:ATYR - Nasdaq - US0021202025 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 84% to ATYR. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 18.76. This target is 451.67% above the current price.
ATYR was analyzed by 17 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about ATYR.
In the previous month the buy percentage consensus was at a similar level.
ATYR was analyzed by 17 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-02-18 | Leerink Partners | Initiate | Outperform |
| 2025-01-06 | Cantor Fitzgerald | Initiate | Overweight |
| 2024-12-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-03 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-29 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-04 | Wells Fargo | Initiate | Overweight |
| 2024-09-05 | Jefferies | Initiate | Buy |
| 2024-08-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-14 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-08-01 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-07-22 | HC Wainwright & Co. | Reiterate | Buy -> Buy |